Internal Medicine, Hematology & Oncology · Somerset, NJ
NPI
1487776373
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
75 Veronica Ave, Suite 201
Somerset, NJ, 08873
Phone (732) 246-4882
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.0M
143,511 services
Medicare patients, 2024
816
Average age 76
Drug cost, 2024
$5.7M
1,780 prescriptions
Company payments, 2025
$3,351
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sameer P Desai was code J1439 (injection, ferric carboxymaltose, 1 mg), 60,750 times for 59 patients. In total Sameer P Desai billed 143,511 services in 140 codes, and Medicare paid $2.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-05-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 60,750 | 59 | $0.86 | $52K |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 4,620 | 16 | $19.32 | $89K |
| J0897 Injection, denosumab, 1 mg | Office | 2,820 | 23 | $20.49 | $58K |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 2,780 | 14 | $35.24 | $98K |
| 36415 Venipuncture Blood Collection | Office | 1,175 | 452 | $8.64 | $10K |
| 99214 Office E&M - Established | Office | 780 | 401 | $99.80 | $78K |
| 85025 Blood Count | Office | 737 | 239 | $7.61 | $5,609 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 710 | 27 | $0.09 | $63.8 |
| 96372 Injection Administration | Office | 472 | 123 | $11.98 | $5,653 |
| 99232 Hospital E&M - Subsequent | Facility | 355 | 143 | $65.66 | $23K |
| 85027 Blood Count | Office | 344 | 128 | $6.32 | $2,175 |
| 96367 Intravenous Infusion, Hydration | Office | 221 | 58 | $24.99 | $5,523 |
| 99213 Office E&M - Established | Office | 199 | 116 | $72.31 | $14K |
| 96365 Intravenous Infusion, Hydration | Office | 188 | 107 | $55.17 | $10K |
| 96413 Chemotherapy Administration | Office | 181 | 64 | $113.32 | $21K |
By year: 2022 $1.5M for 134,551 services; 2023 $1.8M for 132,661 services; 2024 $2.0M for 143,511 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,175 | 452 | $8.64 | $10K |
| 85025 Blood Count | 737 | 239 | $7.61 | $5,609 |
| 85027 Blood Count | 344 | 128 | $6.32 | $2,175 |
Medicare prescription drug claims, 2024
In 2024, the drug Sameer P Desai prescribed most often to Medicare patients was Anastrozole, with 138 prescriptions and refills. In total Sameer P Desai wrote 1,780 Medicare prescriptions that cost $5.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 138 | 362 | 46 | $3,136 |
| Eliquis Apixaban | 114 | 173 | 22 | $102K |
| Aranesp Darbepoetin Alfa In Polysorbat | 91 | 91 | 20 | $225K |
| Hydroxyurea Generic | 91 | 159 | 19 | $2,009 |
| Procrit Epoetin Alfa | 78 | 78 | 17 | $118K |
| Neulasta Pegfilgrastim | 61 | 61 | 16 | $518K |
| Xarelto Rivaroxaban | 56 | 84 | 11 | $46K |
| Prednisone Generic | 53 | 88 | 19 | $348 |
| Abiraterone Acetate Generic | 44 | 46 | Under 11 | $110K |
| Revlimid Lenalidomide | 38 | 38 | Under 11 | $710K |
| Warfarin Sodium Generic | 35 | 91 | Under 11 | $513 |
| Anagrelide Hcl Generic | 34 | 56 | Under 11 | $2,500 |
| Jakafi Ruxolitinib Phosphate | 25 | 25 | Under 11 | $433K |
| Folic Acid Generic | 25 | 75 | 11 | $296 |
| Lupron Depot Leuprolide Acetate | 23 | 67 | Under 11 | $124K |
Brand drugs: - claims; generic drugs: 904 claims; opioid claims: 41.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sameer P Desai $3,351 ($3,351 in general payments such as food, travel and fees) from 29 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $1,435.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 4 | $1,435 |
| Taiho Oncology, Inc. 4578.T | 1 | $1,130 |
| Astellas Pharma US Inc 4503.T | 4 | $66.26 |
| Aveo Pharmaceuticals, Inc. | 2 | $60.41 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 3 | $56.21 |
| Genzyme Corporation SNY | 2 | $46.94 |
| Jazz Pharmaceuticals Inc. JAZZ | 2 | $37.75 |
| Telix Pharmaceuticals TLX | 2 | $36.95 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $36.19 |
| Blueprint Medicines Corporation SNY | 2 | $35.94 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.